Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations
San Diego, USA — January 23, 2024. Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, proudly announces that its global laboratory facilities have successfully passed a series of annual on-site ISO audits, achieving a flawless record with zero discrepancies.
In addition to these certifications, Crown Bioscience’s facilities renewed accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), while its facility in Germany also recently secured approval from the College of American Pathologists (CAP).
Auditing experts lauded the company’s dedication to quality, health and safety, and environmental management, with perfect scores at all facilities.
In parallel to these audits, Crown Bioscience launched its Electronic Laboratory Notebook project, an initiative that digitizes end-to-end laboratory operations and simultaneously strengthens the integrity and precision of laboratory data, further establishing the company as a leader in the field.
The ongoing development and improvement of the ISO management systems and processes emphasize Crown Bioscience's focus on delivering high-quality services, meeting client requirements efficiently, and elevating satisfaction levels for both clients and employees.
Pam Shang, EMBA, Vice President of Global Quality and Regulatory Compliance, said: ‘’We take immense pride in our diligent teams. Their excellent work in the rigorous ISO audits is a testament to our quality and safety commitment, enabling us to serve our customers better on a global scale. We believe that these achievements will bolster our growth and foster ongoing relationships with our existing clients.’’
Crown Bioscience is delighted to receive these recognitions, which highlight the unwavering commitment to excellence. The company foresees that these accomplishments will pave the way for continued success and expansion in preclinical translational science, with a global impact on health and the future of precision medicine.
Contact details
-
- Missy Bindseil
-
JSR Life Sciences Company Inquiries
Director, Marketing & Communications - mbindseil@jsr-nahq.com
Related topics
Related news
Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services
Crown Bioscience today announced the dual attainment of College of American Pathologists (CAP) accreditations for its medical laboratory services.
Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024
Crown Bioscience is set to display significant advances in preclinical and translational oncology research at a prominent cancer research meeting, AACR 2024. The company's contributions to the cont...
Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row
Crown Bioscience secures the T+ Employer® certification for healthcare excellence every year since the award was inaugurated in 2020.
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Scre...
Crown Bioscience has launched OrganoidXplore, a revolutionary platform for large-scale screening of patient-derived organoids that accelerates preclinical oncology drug discovery. The platform repl...